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HISTORICAL ASPECTS
I gE mediated anaphylaxis was first documented in 2641 B.C., when King Menses was stung to death by a wasp or hornet according to hieroglyphics. I The first scientific description of anaphylaxis was in dogs, secondary to an allergic reaction to toxin from a sea anemone? As allergenic substances became available, such as horse serum used as an antitoxin, reports of anaphylaxis occurred, and penicillin was identified as a major problem in the mid 20th century. Thus, the allergen had to be available for anaphylaxis to that agent to be described.
Idiopathic Anaphylaxis (IA) was first described in 1978. 3 A point to consider is that anaphylaxis to hymenoptera stings was first apparent in 2641 B.C., but correlation of food anaphylaxis was not defined until early in the 20th century and was initially termed food "poisoning."4 Thus, food anaphylaxis (like hymenoptera anaphylaxis) probably existed for thousands of years. Similarly, it can be postulated that IA did not have its onset in the last quarter of this century, but occurred for thousands of years without recognition of what the disease was. Unfortunately, the diagnosis is frequently missed even at the present time.
CLASSIFICA nON OF IA
A s increasing numbers of cases of IA were seen, it became possible to classify the cases in terms of major clinical presentation, i.e., Generalized (G) or life threatening Angioedema (A). Further, the frequency of episodes were classified as frequent (F) or infrequent (I). The current classification of IA is shown in Table II. TREATMENT OF IA A s increasing numbers of cases of IA were seen, both acute and preventative treatment regimens were designed and used. These were initially based on regimens used to prevent radiographic contrast media reactions 5 and are shown in Figure 1 . These treatment regimens were shown to be effective. initiation of treatment. This is in contrast to the outcome of patients with severe prednisone dependent asthma.
SPECIAL PROBLEMS IN IA
Undifferentiated Somatoform IA T his diagnosis defines patients who have a psychiatric disease and express this by reporting symptoms that appear to be IA. s The diagnosis is one of exclusion by failure to find objective evidence of documentation of physical findings consistent with IA in Emergency Service ex-312 aminations and usually failure to respond to the regimen for IA. The prognosis is poor as the concept of psychiatric disease is rejected by the patient and sometimes by the personal physician. These patients may be treated with excess doses of prednisone with the expected side effects.
Pediatric IA T here is a lower incidence of IA in the pediatric population, but this does occur and is frightening to patients and families. 9 ,10 Fortunately, the pediatric IA cases respond to the same regimen developed for adult cases of lA, with appropriate adjustment of doses for body weight.
Fatalities from IA F atalities have been reported ll and it is very likely that far more fatalities have occurred than have been reported because of failure to describe the disease for decades (or centuries as described in the introductory statements) and failure to make the diagnosis even at the present time.
Corticosteroid Dependent IA T his refers to patients whose prednisone dosage cannot be lowered below a certain threshold. Zaditen (ketotifen), a mast cell stabilizer not available in the U.S., is helpful in many such cases. 12 Patient Education P atients with lA, and at times the referring physician, may not accept the diagnosis and lack of an external allergen as a triggering event. Further, the use of prednisone alarms some patients and their personal physicians. For these reasons we published a book on lA, from which we receive no royalties, so that a comprehensive source of information was available to patients and their physicians. 13 Potential Mechanisms of IA T hese have been discussed in detail by Grammer. 14 The explanation for IA reactions is unknown, and it may be decades before the mechanisms are established for IA-G and lA-A. These two types of IA may differ in the mechanisms responsible. Possible mechanisms to be considered are as follows. An autoimmune mechanism such as IgG antibodies against IgE fixed to mast cells or IgG antibodies against the IgE receptor on mast cells are both possible mechanisms. The action of histamine releasing factors is another mechanism to be studied. A major problem in evaluating mechanisms is that patients with IA-F must have treatment started immediately to prevent fatalities, and the mechanism responsible for IA may be altered by the IA therapeutic regimen.
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